| Product Name | 1,2,3,4,6-O-pentagalloylglucose |
|---|---|
| CAS | 14937-32-7 |
| Formula | C41H32O26 |
| MW | 940.68 |
| Appearance | 棕色粉末 |
| Melting point | 143 °C |
| Boiling point | 1365.7±65.0 °C | Condition: Press: 760 Torr |
| PKa | 8.37±0.15 | Condition: Most Acidic Temp: 25 °C |
| Product Name | 1,2,3,4,6-O-pentagalloylglucose |
|---|---|
| CAS | 14937-32-7 |
| Formula | C41H32O26 |
| MW | 940.68 |
| Appearance | 棕色粉末 |
| Melting point | 143 °C |
| Boiling point | 1365.7±65.0 °C | Condition: Press: 760 Torr |
| PKa | 8.37±0.15 | Condition: Most Acidic Temp: 25 °C |
WKQ-0000008
中文名稱：1,2,3,4,6-O-五沒食子酰葡萄糖
中文別名：β-五沒食子酰葡萄糖；五沒食子酰葡萄糖
英文名稱：1,2,3,4,6-O-pentagalloylglucose
英文別名：Gallic acid, pentaester with β-D-glucopyranose (6CI);Glucopyranose, pentagallate, β-D- (8CI);β-D-Glucopyranose, pentakis(3,4,5-trihydroxybenzoate) (9CI);1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranose;1,2,3,4,6-Penta-O-galloyl-β-D-glucopyranoside;1,2,3,4,6-Penta-O-galloyl-β-D-glucose;1,2,3,4,6-Penta-O-galloyl-β-D-glucoside;1,2,3,4,6-Penta-O-galloyl-β-glucopyranose;1,2,3,4,6-Penta-O-galloylglucose;1,2,3,4,6-Pentagalloyl-β-D-glucopyranose;1,2,3,4,6-Pentagalloyl-β-D-glucopyranoside;1,2,3,4,6-Pentagalloyl-β-D-glucose;DB 03208;G 7548;Gallotannin 15;Penta-O-galloyl-β-D-glucopyranose;Penta-O-galloyl-β-D-glucose;Penta-O-galloylglucose;Pentagalloyl-D-glucose;β-1,2,3,4,6-Pentagalloylglucose;
分子式：C41H32O26
分子量：940.68
CAS號：14937-32-7
純度：HPLC≥98%
熔點：143 °C
沸點：1365.7±65.0 °C | Condition: Press: 760 Torr
密度：2.05±0.1 g/cm3 | Condition: Temp: 20 °C Press: 760 Torr
酸系度數(shù)：8.37±0.15 | Condition: Most Acidic Temp: 25 °C
儲存條件：-20℃，干燥、避光、密封
規(guī)格：5mg10mg20mg50mg100mg500mg1g2g等應(yīng)客戶需求包裝
供應(yīng)單位：四川省維克奇生物科技有限公司
供應(yīng)電話：028-81700200/4008005713
四川省維克奇生物科技有限公司生產(chǎn)中藥類標(biāo)準(zhǔn)品和天然植物有效單體，主打中藥對照品/標(biāo)準(zhǔn)品/天然植物有效單體，化學(xué)合成，抗生素三大板塊。公司推出丹參系列、龍膽系列、蟲草系列等，敬請關(guān)注！ 新批次有現(xiàn)貨，歡迎咨詢。
| In vitro study of anti-ER positive breast cancer effect and mechanism of 1,2,3,4-6-pentyl-O-galloyl-beta-d-glucose (PGG) | ||
| Source:SCI：BIOMEDICINE & PHARMACOTHERAPY | Author:Qiu Xiang | Notes：影響因子：3.743 |
| Reference description | ||
1,2,3,4,6-penta-O-galloyl-β-d-glucopyranose (PGG, CAS. NO.14937-32-7) was purchased from Sichuan Weikeqi Biotechnology Co., Ltd. (China); Dulbecco's modified Eagle's medium (DMEM) was purchased from Thermo Fisher Scientific(Gibco, USA); Fetal bovine serum (FBS, Cat. NO.11011-8611) was purchased from Zhejiang Tianhang Biotechnology Co., Ltd. (China) | ||
| Pentagalloylglucose suppresses the growth and migration of human nasopharyngeal cancer cells via the GSK3β/β-catenin pathway in vitro and in vivo | ||
| Source:SCI：PHYTOMEDICINE | Author:Cai-Wen Fan | Notes：影響因子：5.34 |
| Reference description | ||
PGG (Fig. 1A), a gallotannin polyphenol derivative (purity > 98.0% by HPLC analysis), was purchased from Weikeqi Biotechnology (Sichuan, China). PGG was dissolved in ethanol, and the final concentration of ethanol was less than 0.1% during treatment. A FITC Annexin V Kit was purchased from BD Biosciences (San Jose, CA, USA). | ||
